What is CVE-2020-27260?

CVE-2020-27260 is a medium-severity vulnerability in Innokasmedical Vital Signs Monitor Vc150, classified under Improper Neutralization of Special Elements in Output Used by a Downstream Component (Injection). CVSS score: 5.3/10. Published 2021-01-08.

How severe is CVE-2020-27260?

Medium severity. CVSS v3 base score is 5.3 out of 10.

Vulnerability in Innokasmedical Vital Signs Monitor Vc150

CVE-2020-27260

Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages via multiple expected parameters.

EPSS: 0.004 (35.5th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N.

Affected products

Innokasmedical Vital_signs_monitor_vc150
Innokasmedical Vital_signs_monitor_vc150_firmware
N/a Bigcompanysoft Software Product — versions VC150 prior to Version 1.7.15

Weakness classification (CWE)

CWE-74 — Improper Neutralization of Special Elements in Output Used by a Downstream Component (Injection)

References

ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2020-27260?: CVE-2020-27260 is a medium-severity vulnerability in Innokasmedical Vital Signs Monitor Vc150, classified under Improper Neutralization of Special Elements in Output Used by a Downstream Component (Injection). CVSS score: 5.3/10. Published 2021-01-08.
How severe is CVE-2020-27260?: Medium severity. CVSS v3 base score is 5.3 out of 10.